Stay updated on Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays the clinical trial record for the ipilimumab, nivolumab, and radiation therapy study, including study details, eligibility criteria, outcomes, and posted results. It also provides links to the study protocol and informed consent form.
    Difference
    63%
    Check dated 2026-11-08T15:18:19.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:21:43.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A notice banner announces the NIH website transition and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T17:45:12.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:16:59.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1 on the error page.
    Difference
    0.2%
    Check dated 2026-10-11T22:08:46.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error for the study record, signaling access restrictions, while much of the surrounding institutional content and documents are removed, leaving an error screen instead of the usual study details.
    Difference
    21%
    Check dated 2026-09-20T20:52:36.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.